Stay updated on CAB-AXL-ADC in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.

Latest updates to the CAB-AXL-ADC in Sarcoma Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer reflects an update to the ClinicalTrials.gov site revision (moving from v3.5.2 to v3.5.3), indicating a platform/version change rather than an update to the trial record itself.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study details or page functionality are indicated by this update.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedMalignant fibrous histiocytoma is added as a related term, and the Genetic and Rare Diseases Information Center resources are now listed.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated to v3.4.3 and previous revision v3.4.2 removed.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 in the page header. No substantive trial content or details were altered.SummaryDifference0.0%

Stay in the know with updates to CAB-AXL-ADC in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.